摘要
为探讨新辅助介入化疗在局部晚期宫颈癌合并混合痔中的应用效果及对生存期的影响,回顾分析100例局部晚期宫颈癌合并混合痔患者临床资料,按治疗方法分为对照组30例和试验组70例。对照组采取新辅助静脉化疗,试验组采取新辅助介入化疗,对比观察2组治疗效果、生存期等。结果显示,与对照组相比,试验组术中出血量,手术时间显著减少(P<0.05);治疗效果、手术率和生存率均得到显著改善(P<0.05)。结果表明,实施新辅助介入化疗在局部晚期宫颈癌合并混合痔患者中的效果理想,能够有效提高治疗效果,改善患者生存质量,极具研究与应用价值。
This study was to explore the efficacy of neoadjuvant intervention chemotherapy(NAICT)for late cervical carcinoma complicated with mixed hemorrhoids,and its influence on patients’survival duration,retrospectively analysed the clinical data of 100 patients with local late cervical carcinoma associated with mixed hemorrhoids who were divided into two groups according to treatment methods,i.e,control group(30 cases,adopted neoadjuvant venous chemotherapy)and trial group(30 cases,NAICT);then compared both groups’effect and survival duration,etc norms.As results,compared with control group in trial group intraopeartive bleeding volume and operating time were significantly reduced(P<0.05);And,treatment efficacy,operating rate and survival rate all got significantly improved(P<0.05).Results show that NAICT for late carcinoma carcinoma complicated with hemorrhoids can achieve ideal efficacy,improve patients’quality of life.It has great research and application value.
作者
安存莲
AN Cun-lian(Wuwei Oncology Hospital of Gansu Province,Wuwei,Gansu 733000)
出处
《中国肛肠病杂志》
2019年第12期62-63,共2页
Chinese Journal of Coloproctology
关键词
晚期宫颈癌
混合痔
新辅助介入化疗
疗效
生存期
Advanced cervical carcinoma
Mixed hemorrhoids
Neoadjuvant intervention chemotherapy
Effect
Survival duration
